New imaging drugs could spot brain changes in rare PSP
NCT ID NCT07348276
First seen Jan 17, 2026 · Last updated May 01, 2026 · Updated 15 times
Summary
This study tests two new imaging drugs that light up tau protein clumps in the brain during a PET scan. Researchers want to see if they are safe and can help diagnose Progressive Supranuclear Palsy (PSP), a rare movement and thinking disorder. About 24 adults—some healthy, some with PSP—will receive the drugs and undergo scans. The goal is to create better tools for spotting PSP early and tracking its progression.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Invicro (dba Perceptive)
RECRUITINGNew Haven, Connecticut, 06510, United States
Contact Phone: •••-•••-••••
Conditions
Explore the condition pages connected to this study.